Pricing

Exalys Therapeutics

0 followers

‌

Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.

Industries

Biotechnology, Education

Employees

11-50

Links

Org chart

Rick Orr

CEO

Rick Orr

Collapse

Julien Mamet

Chief Scientific Officer

Shashidhar Kori

Chief Medical Officer

Lynne Rollins

Chief Financial Officer

William Martin

EVP, Corporate Development & Operations

Teams

Executive Management

5 members

Leadership Team

5 members

Advisory Team

4 members

Similar companies

Artiva Biotherapeutics

1 follower

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Verve Therapeutics

54 followers

Tarsus Pharmaceuticals

1 follower

Thermo Fisher Scientific

158 followers

Babson College

14 followers

Sonoma Biotherapeutics

1 follower

CRISPR Therapeutics

9 followers

University of Ottawa

9 followers

Adverum Biotech

8 followers

Explore companies